View Archive: 2012  |  2011  |  2010  |  2009  |  2008  |  2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000  |  1999  |  1998

December 20, 2006
Cytokinetics Announces Initiation of Phase II Clinical Trial in Renal Cell Cancer and Phase I Clinical Trial in Pediatric Solid Tumors

December 13, 2006
Cytokinetics Announces Four Research Posters at the 46th Annual American Society for Cell Biology Meeting

December 11, 2006
Cytokinetics Announces Non-Clinical Poster Presentation Regarding Ispinesib at the 2006 Annual Meeting of American Society of Hematology

December 7, 2006
Cytokinetics to Present at the 2006 RBC Capital Markets Healthcare Conference

December 7, 2006
Cytokinetics Announces Non-Clinical Data Regarding Ispinesib to be Presented at the 2006 Annual Meeting of American Society of Hematology

December 7, 2006
Cytokinetics Announces Registered Direct Common Stock Offering of $37 Million

December 5, 2006
Cytokinetics Announces Four Scientific Posters to be Presented at the 46th Annual American Society of Cell Biology Meeting

December 1, 2006
Cytokinetics Announces Oral Bioavailability Results for CK-1827452

November 27, 2006
Cytokinetics and GlaxoSmithKline Amend Collaboration and License Agreement

November 20, 2006
Cytokinetics to Present at Lazard Capital Markets Life Sciences Conference

November 15, 2006
Cytokinetics Announces Presentations of Clinical Trial Data on CK-1827452 and Non-Clinical Data from its Cardiac Myosin Activator Program Presented at the 2006 Annual American Heart Association Scientific Sessions Meeting

November 10, 2006
Cytokinetics Announces Clinical Trial Data with Ispinesib and Non-clinical Data with SB-743921 at the EORTC-NCI-AACR Symposium

November 9, 2006
Cytokinetics to Present at Two Upcoming Investor Healthcare Conferences

November 6, 2006
Cytokinetics Announces Presentations Relating to Clinical Trial Data on CK-1827452 and its Cardiac Myosin Activator Program at the 2006 Annual American Heart Association Scientific Sessions Meeting

November 3, 2006
Cytokinetics Announces Clinical Trial Data with Ispinesib and Non-clinical Data with SB-743921 to be Presented at the 2006 EORTC-NCI-AACR International Meeting

October 31, 2006
Cytokinetics to Present at the Rodman and Renshaw 8th Annual Healthcare Conference

October 26, 2006
Cytokinetics, Incorporated Reports Third Quarter 2006 Financial Results

October 19, 2006
Cytokinetics to Announce Third Quarter Results on October 26, 2006

October 11, 2006
Cytokinetics to Present at BIO InvestorForum 2006

October 2, 2006
Cytokinetics Reports Data for Ispinesib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

September 13, 2006
Cytokinetics Announces Presentation of Phase I Clinical Trial Data for CK-1827452 During Recent and Late Breaking Trials Session

September 5, 2006
Cytokinetics to Present Clinical and Non-Clinical Data on Selective Cardiac Myosin Activator CK-1827452 at the 2006 Annual Heart Failure Society of America Meeting

August 23, 2006
Cytokinetics Announces Initiation of Phase I Clinical Trial for Oral Administration of CK-1827452

July 27, 2006
Cytokinetics, Incorporated Reports Second Quarter 2006 Financial Results

July 20, 2006
Cytokinetics to Announce Second Quarter Results on July 27, 2006

June 29, 2006
Cytokinetics Announces Positive Phase I Clinical Trial Results for CK-1827452

June 19, 2006
Cytokinetics Announces the Extension of Research Collaboration with GlaxoSmithKline

June 6, 2006
Cytokinetics to Present at Three Upcoming Investor Healthcare Conferences

June 5, 2006
Cytokinetics Announces the Presentation of Clinical Trials Data at the 2006 Annual Meeting of the American Society of Clinical Oncology

May 22, 2006
Cytokinetics to Hold Annual Meeting of Stockholders

April 27, 2006
Cytokinetics, Incorporated Reports First Quarter 2006 Financial Results

April 25, 2006
Cytokinetics to Present at the Deutsche Bank Securities 31st Annual Health Care Conference

April 24, 2006
Cytokinetics Announces Clinical Trials Data to be Presented at the 2006 Annual Meeting of The American Society of Clinical Oncology

April 20, 2006
Cytokinetics to Announce First Quarter Results on April 27, 2006

April 17, 2006
Cytokinetics Announces the Initiation of Phase I/II Clinical Trial for SB-743921

March 30, 2006
Cytokinetics Reports Data for Ispinesib (SB-715992) in Platinum-Sensitive Non-Small Cell Lung Cancer

March 2, 2006
Cytokinetics to Present at the Lehman Brothers Ninth Annual Global Healthcare Conference

February 28, 2006
Cytokinetics to Present at the Fifth Annual JMP Securities Research Conference

February 8, 2006
Cytokinetics to Present at the BIO CEO & Investor Conference 2006

January 31, 2006
Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2005 Financial Results

January 24, 2006
Cytokinetics to Release Fourth Quarter and Full Year 2005 Results on January 31, 2006

January 18, 2006
Cytokinetics Announces $33 Million Financing